This review synthesizes preclinical evidence showing that cinnamon-derived compounds can modulate inflammation, oxidative ...

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology.

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

Researchers have identified the mechanism by which cancer cells create their own growth signals to proliferate, independent ...

P-cadherin is a protein commonly found on malignant cancer cells and has been used as a target for antibody-based cancer treatments. UC Davis biomedical engineers have discovered that when an antibody ...

The biotech will now take atebimetinib to mid- and late-stage trials in NSCLC and pancreatic cancer, respectively.

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

Groundbreaking research reveals that common blood sugar medications do more than manage glucose—they are actively reshaping ...

Cirtuvivint is a selective pan-CLK, pan-DYRK inhibitor that modulates alternative RNA splicing, including transcripts involved in oncogenic pathways. Preclinical studies have shown that CLK/DYRK ...